JPM 2022: Bristol Myers buoys cell therapy interests with $3B biobucks deal with Bayer-backed Century, $70M upfront to ArsenalBio

The two cell therapy deals, announced at J.P. Morgan Healthcare Conference, gives BMS access to natural killer cell and t-cell research in blood and solid tumors. (Bristol Myers Squibb) https://www.fiercebiotech.com/biotech/bristol-myers-signs-3b-biobucks-deal-century-for-cell-therapies-for-hematologic-solid

Rate this:

Read Article →

Elizabeth Holmes, Theranos, & lessons for the stem cell field

Elizabeth Holmes at 2015 Fortune Global Forum. Photograph by Stuart Isett/Fortune Global Forum. Creative Commons license. https://ipscell.com/2022/01/elizabeth-holmes-theranos-lessons-for-the-stem-cell-field/?utm_source=mailpoet&utm_medium=email&utm_campaign=new-post-from-the-niche_11%5B/

Rate this:

Read Article →

T Cells: No Time To Die – At the Forefront in the Fight Against Viruses, Bacteria, and Malignant Cells

Coronin 1 promotes long-term survival of the T cells of our immune system. Credit: Nano Imaging Lab SNI/Biozentrum, University of Basel https://scitechdaily.com/t-cells-no-time-to-die-at-the-forefront-in-the-fight-against-viruses-bacteria-and-malignant-cells/

Rate this:

Read Article →